Wave Life Sciences Investor Presentation 2022

Wave Life Sciences is building a leading genetic medicines company leveraging stereopure oligonucleotides and novel backbone chemistry modifications. The company targets multiple disease areas including ALS, frontotemporal dementia, Huntington's disease, Duchenne muscular dystrophy, and Alpha-1 antitrypsin deficiency through its innovative transcriptome-targeting platform.